ROSSARI quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Rossari Biotech Ltd reported sales of ₹698 Cr, operating profit of ₹87 Cr (OPM 12%) and net profit of ₹39 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
ROSSARI quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
513
580
544
586
582
685
697
698
Expenses
448
510
476
514
513
608
617
611
Operating Profit
65
69
68
72
69
77
81
87
OPM
13%
12%
12%
12%
12%
11%
12%
12%
Other Income
1
2
2
2
1
20
4
1
Interest
5
6
6
6
8
9
11
9
Depreciation
18
18
18
18
20
24
26
30
Profit before tax
42
48
46
50
43
64
48
49
Tax
25%
28%
27%
26%
23%
28%
26%
21%
Net Profit
32
34
34
37
33
46
35
39
EPS in Rs
5.73
6.22
6.07
6.66
5.92
8.3
6.34
7.02
ROSSARI profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
1,483
1,656
1,831
2,080
2,396
2,661
Expenses
1,299
1,433
1,581
1,815
2,110
2,348
Operating Profit
184
223
250
265
286
314
OPM
12%
13%
14%
13%
12%
12%
Other Income
13
6
8
5
24
25
Interest
13
22
19
18
29
36
Depreciation
48
63
60
67
79
99
Profit before tax
136
144
178
185
203
204
Tax
28%
26%
26%
26%
26%
-
Net Profit
98
107
131
136
149
153
EPS in Rs
17.74
19.45
23.66
24.63
26.94
27.58
Dividend Payout
3%
3%
2%
2%
2%
-
ROSSARI balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
11
11
11
11
11
Reserves
1,037
1,174
1,240
1,322
1,397
Borrowings
119
218
353
436
388
Other Liabilities
401
482
484
505
564
Total Liabilities
1,567
1,886
2,088
2,274
2,359
Fixed Assets
578
598
630
784
845
CWIP
47
140
247
173
156
Investments
63
84
20
62
30
Other Assets
880
1,063
1,190
1,254
1,328
Total Assets
1,567
1,886
2,088
2,274
2,359
ROSSARI cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
29
152
43
137
65
Cash from Investing Activity
-299
-181
-103
-183
-220
Cash from Financing Activity
292
61
16
65
186
Net Cash Flow
22
32
-44
19
31
Free Cash Flow
-7
120
-83
-21
-175
CFO/OP
43%
89%
39%
74%
47%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit